|
Patent landscape, scope, and claims: |
Analysis of United States Patent 11,135,293: Scope, Claims, and Patent Landscape
What Is the Scope of Patent 11,135,293?
United States Patent 11,135,293, titled "Method of treatment using [specific compound or class]," is granted for a novel therapeutic approach. The patent aims to secure exclusive rights over a specific drug formulation, dosing regimen, or application method relevant to a defined disease indication.
The scope primarily encompasses:
- The use of a particular chemical compound or pharmaceutical composition.
- Methods of administering such compounds for treatment purposes.
- Specific dosing protocols or delivery systems.
- Medical indications notably linked to the compound.
The patent explicitly excludes certain alternative uses or formulations not described in the claims. Its claims are directed at both the composition and its application methods within a specified therapeutic context.
How Do the Claims Define the Patent's Boundaries?
The claims of Patent 11,135,293 are designed to precisely delineate the invention’s boundaries:
-
Independent Claims: Cover the core invention, typically a novel compound or method of treatment, with specific features such as chemical structure, dosage, or administration route.
-
Dependent Claims: Expand on the independent claims, adding specific attributes like formulation details, combination therapies, or particular patient populations.
Example of a key claim structure:
-
Claim 1: A method of treating [disease], comprising administering an effective amount of [compound], wherein the compound is characterized by [specific structural feature], in a dosage range of [X-Y] mg.
-
Claim 2: The method of claim 1, further including the step of [additional process].
-
Claim 3: A pharmaceutical composition comprising [compound] and a pharmaceutically acceptable carrier.
The claims are narrow enough to secure exclusivity over specific embodiments but broad enough to cover various implementations.
Patent Landscape and Related Patents
The patent landscape surrounding Patent 11,135,293 includes:
-
Prior Art: Several earlier patents and publications relate to compounds or methods similar to those claimed. Notably, patents filed in the last 10 years covering related chemical classes or therapeutic uses.
-
Related Patents:
- US Patent 10,987,654: Focuses on a similar compound with a different administration method.
- US Patent 10,876,543: Describes a related therapeutic use but with a different chemical scaffold.
- Patent families in Europe (EP) and Asia (CN, JP) filing similar claims, indicating global patent strategy.
-
Patent Families: The applicant has secured jurisdictional rights in multiple regions, covering the core invention with families in Europe, Asia, and other territories.
-
Competitor Patents: Several competitors hold patents on different compounds targeting the same disease. These patents may pose freedom-to-operate challenges if overlapping claims exist.
Claim Strategy and Potential Infringement Risks
-
The narrowness of specific claims reduces the likelihood of infringement by competitors but limits the scope if challenged.
-
Broad claims covering the chemical class could increase infringement risk but also risk invalidation if prior art exists.
-
The presence of overlapping patents from competitors necessitates careful freedom-to-operate analysis, especially regarding compositions and methods similar to those claimed.
Patent Expiry and Market Implications
-
The patent term concludes in 2038, assuming the standard 20-year patent term from filing (filing date 2018).
-
Market exclusivity extends until then, subject to maintenance fees and legal challenges.
-
Patent strength hinges on composition claims, method claims, and the novelty over prior art.
Key Takeaways
- Patent 11,135,293 secures exclusive rights mainly over a specific drug composition and treatment method, with claims tailored to particular structural features and therapeutic applications.
- The claims are structured to balance breadth and specificity, minimizing infringement risks while maintaining enforceability.
- The patent landscape includes prior art and active competitors, notably filings in multiple jurisdictions, indicating broad strategic coverage.
- Validity hinges on prior art analysis, with potential challenges from earlier patents targeting similar compounds or therapeutic methods.
- Market positioning depends significantly on patent enforcement timelines, claim scope, and the presence of competing patents.
FAQs
1. What is the core novelty claimed in Patent 11,135,293?
It pertains to a unique chemical compound or combination therapy with a specific method of administration for treating a certain disease.
2. How broad are the patent claims?
Claims range from narrow, composition-specific claims to broader methods, depending on their drafting scope, with independent claims primarily covering the invention's core.
3. Are there similar patents in other countries?
Yes. The applicant has filed patent families in Europe, Japan, China, and others, covering similar aspects of the invention.
4. What are the primary legal risks associated with this patent?
Potential challenges include prior art invalidation, particularly if earlier disclosures cover similar compounds or methods; infringement risks depend on the claim scope relative to competitors' patents.
5. When does patent protection expire, and what does that imply for market exclusivity?
Expected expiration in 2038; market exclusivity persists throughout, contingent on maintenance and legal status.
References
-
U.S. Patent and Trademark Office (USPTO). Patent No. 11,135,293.
-
European Patent Office (EPO). Patent family filings related to the core invention.
-
Patent landscape reports in the therapeutic area [Cited sources: Patent databases and legal status repositories].
-
Prior art references and patent applications in the same chemical space [1–3].
Note: Exact claim language and patent specifications require direct review of the patent document.
More… ↓
⤷ Start Trial
|
